nach oben

Current Atherosclerosis Reports

Erschienen in:

01.06.2014 | Cardiovascular Disease and Stroke (P Perrone-Filardi and S. Agewall, Section Editors)

An International Smoking Ban—How Many Lives Will Be Saved?

verfasst von: Cecily C Kelleher, Kate Frazer

Erschienen in: Current Atherosclerosis Reports | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Multicomponent tobacco control strategies are crucial to combat the ongoing global smoking challenge. In the twenty-first century, many countries have signed up to the World Health Organization Framework Convention on Tobacco Control, and in recent years a mounting number of countries and regions have implemented partial or complete smoking bans to protect the general public from passive smoke exposure. There is substantial evidence that workers, particularly in the hospitality sector, benefit from reduced exposure. More recently, several reports have appeared from different countries showing a temporal relationship between the introduction of a smoking ban and reduced hospital admissions for cardiovascular, respiratory and maternity outcomes. This will have a measurable benefit for public health, saving many lives. Multicomponent strategies could also reduce active smoking significantly if successfully implemented worldwide.

Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA. 2014;311(2):183–92.PubMedCrossRef

World Health Organization. Framework convention on tobacco control. Geneva: World Health Organization; 2003.

Levy DT, Ellis JA, Mays D, Huang A-T. Smoking-related deaths averted due to three years of policy progress. Bull World Health Organ. 2013;91:509–18.

van Amsterdam J, Pennings E, Brunt T, van den Brink W. Physical harm due to chronic substance use. Regul Toxicol Pharmacol. 2013;66(1):83–7.PubMedCrossRef

Illman J. European commission publishes cancer code, continues providing subsidies to tobacco farmers. J Natl Cancer Inst. 2003;95(16):1187–8.PubMedCrossRef

Freeman B, Chapman S, Rimmer M. The case for the plain packaging of tobacco products. Addiction. 2008;103(4):580–90.PubMedCrossRef

Öberg M, Jaakkola MS, Prüss-Üstün A, Schweizer C, Woodward A. Second-hand smoke: Assessing the environmental burden of disease at national and local levels. WHO environmental burden of disease series no 18. Geneva: World Health Organization; 2010.

Callinan JE, Clarke A, Doherty K, Kelleher C. Legislative smoking bans for reducing secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst Rev. 2010;4:CD005992.PubMed

Proctor RN. Why ban the sale of cigarettes? The case for abolition. Tob Control. 2013;22 Suppl 1:i27–30.PubMedCentralPubMedCrossRef

10.

Lunze K, Migliorini L. Tobacco control in the Russian Federation- a policy analysis. BMC Public Health. 2013;13:64.PubMedCentralPubMedCrossRef

11.

Gallus S, Rosato V, Zuccaro P, Pacifici R, Colombo P, Manzari M, et al. Attitudes towards the extension of smoking restrictions to selected outdoor areas in Italy. Tob Control. 2012;21(1):59–62.PubMedCrossRef

12.

Basu S, Glantz S, Bitton A, Millett C. The effect of tobacco control measures during a period of rising cardiovascular disease risk in India: a mathematical model of myocardial infarction and stroke. PLoS Med. 2013;10(7):e1001480.PubMedCentralPubMedCrossRef

13.

Cornelsen L, Normand C. Impact of the smoking ban on the volume of bar sales in Ireland: evidence from time series analysis. Health Econ. 2012;21(5):551–61.PubMedCrossRef

14.

Dobson A, Amato K, Rivard C, Lipsher J, Hyland A. Five years after Hawaii smoke free law: tourism and hospitality economic indicators appear unharmed. Hawaii J Med Public Health. 2013;72(10):355–61.

15.

Bala MM, Strzeszynski L, Topor-Madry R, Cahill K. Mass media interventions for smoking cessation in adults. Cochrane Database Syst Rev. 2013;6:CD004704.PubMed

16.

Giovino GA, Villanti AC, Mowery PD, Sevilimedu V, Niaura RS, Vallone DM, et al. Differential trends in cigarette smoking in the USA: is menthol slowing progress? Tob Control. 2013. doi:10.1136/tobaccocontrol-2013-051159.

17.

Johnston V, Liberato S, Thomas D. Incentives for preventing smoking in children and adolescents. Cochrane Database Syst Rev. 2012;10:CD008645.PubMed

18.

Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382(9905):1629–37.PubMedCrossRef

19.

Bell K, Keane H. Nicotine control: E-cigarettes, smoking and addiction. Int J Drug Policy. 2012;23(3):242–7.PubMedCrossRef

20.

Hajek P, Foulds J, Le Houezec J, Sweanor D, Yach D. Should e-cigarettes be regulated as a medicinal device? Lancet Respir Med. 2013;1(6):429–31.PubMedCrossRef

21.

Holmes D. Smoking in Russia: will old habits die hard? Lancet. 2011;378(9795):973–4.PubMedCrossRef

22.

Au WW, Su D, Yuan J. Cigarette smoking in China: public health, science, and policy. Rev Environ Health. 2012;27(1):43–9.PubMedCrossRef

23.

Anger S, Kvasnicka M, Siedler T. One last puff? Public smoking bans and smoking behavior. J Health Econ. 2011;30(3):591–601.PubMedCrossRef

24.

Buonanno P, Ranzani M. Thank you for not smoking: evidence from the Italian smoking ban. Health Policy. 2013;109(2):192–9.PubMedCrossRef

25.

Gorini G. Impact of the Italian smoking ban and comparison with the evaluation of the Scottish ban (Valutazione di impatto della Legge Sirchia e confronto con La Scozia). Epidemiol Prev. 2011;35(3-4 Suppl 1):4–18.

26.

Chang FC, Sung HY, Zhu SH, Chiou ST. Impact of the 2009 Taiwan Tobacco Hazards Prevention Act on smoking cessation. Addiction. 2014;109(1):140–6.PubMedCrossRef

27.

Edwards R, Gifford H, Waa A, Glover M, Thomson G, Wilson N. Beneficial impacts of a national smokefree environments law on an indigenous population: a multifaceted evaluation. Int J Equity Health. 2009;8:12.PubMedCentralPubMedCrossRef

28.

Hackshaw L, McEwen A, West R, Bauld L. Quit attempts in response to smoke-free legislation in England. Tob Control. 2010;19(2):160–4.PubMedCrossRef

29.

Lewis SA, Haw SJ, McNeill A. The impact of the 2006 Scottish smoke-free legislation on sales of nicotine replacement therapy. Nicotine Tob Res. 2008;10(12):1789–92.PubMedCrossRef

30.

Zaloshnja E, Ross H, Levy DT. The impact of tobacco control policies in Albania. Tob Control. 2010;19(6):463–8.PubMedCentralPubMedCrossRef

31.

Nagelhout GE, Levy DT, Blackman K, Currie L, Clancy L, Willemsen MC. The effect of tobacco control policies on smoking prevalence and smoking-attributable deaths. Findings from the Netherlands SimSmoke Tobacco Control Policy Simularion Model. Addiction. 2012:107(2):407–16.

32.

Apsley A, Semple S. Secondhand smoke levels in Scottish bars 5 years on from the introduction of smoke-free legislation. Tob Control. 2012;21(5):511–3.PubMedCrossRef

33.

Bohac DL, Hewett MJ, Kapphahn KI, Grimsrud DT, Apte MG, Gundel LA. Change in indoor particle levels after a smoking ban in Minnesota bars and restaurants. Am J Prev Med. 2010;39(6 Suppl 1):S3–9.PubMedCrossRef

34.

Reijula J, Johnsson T, Kaleva S, Tuomi T, Reijula K. Total prohibition of smoking but not partial restriction effectively reduced exposure to tobacco smoke among restaurant workers in Finland. Int J Occup Med Environ Health. 2013;26(5):682–92.PubMedCrossRef

35.

Durham AD, Bergier S, Morisod X, Locatelli I, Zellweger JP, Huynh CK, et al. Improved health of hospitality workers after a Swiss cantonal smoking ban. Swiss Med Wkly. 2011;141:w13317.PubMed

36.

Lai HK, Hedley AJ, Repace J, So C, Lu QY, McGhee SM, et al. Lung function and exposure to workplace second-hand smoke during exemptions from smoking ban legislation: an exposure-response relationship based on indoor PM2.5 and urinary cotinine levels. Thorax. 2011;66(7):615–23.PubMedCrossRef

37.

Madureira J, Mendes A, Almeida S, Teixeira JP. Positive impact of the Portuguese smoking law on respiratory health of restaurant workers. J Toxicol Environ Health, Part A. 2012;75(13–15):776–87.CrossRef

38.

Fitzpatrick P, Gilroy I, Doherty K, Conlon G, Daly L, Kelleher C. Exempting patients from a smoke-free hospital policy on compassionate grounds. BMJ. 2014;348:g389.PubMedCrossRef

39.

Fitzpatrick P, Gilroy I, Doherty K, Corradino D, Daly L, Clarke A, et al. Implementation of a campus-wide Irish hospital smoking ban in 2009: prevalence and attitudinal trends among staff and patients in lead up. Health Promot Int. 2009;24(3):211–22.PubMedCrossRef

40.

Kennedy RD, Behm I, Craig L, Thompson ME, Fong GT, Guignard R, et al. Smoking cessation interventions from health care providers before and after the national smoke-free law in France. Eur J Public health. 2012;22 Suppl 1:23–8.PubMedCentralPubMedCrossRef

41.

Lewis KE, Shin D, Davies G. Smoking habits and attitudes toward tobacco bans among United Kingdom hospital staff and students. Int J Tuberc Lung Dis. 2011;15(8):1122–6.PubMedCrossRef

42.

Fitzpatrick P, Gilroy I, Doherty K, Clarke A, Comerford D, Daly L, et al. Smoke free campus: strong positive shift in attitudes post implementation but paradox in nursing and medical attitudes. Clin Health Promot. 2012;2(1):12–8.

43.

McCaffrey M, Goodman P, Gavigan A, Kenny C, Hogg C, Byrne L, et al. Should any workplace be exempt from smoke-free law: the Irish experience. J Environ Public Health. 2012;2012:545483.PubMedCentralPubMedCrossRef

44.

Radwan GN, Loffredo CA, Aziz R, Abdel-Aziz N, Labib N. Implementation, barriers and challenges of smoke-free policies in hospitals in Egypt. BMC Res Notes. 2012;5:568.PubMedCentralPubMedCrossRef

45.

Stillman FA, Kaufman MR, Zhen A, Yang J, Wang JS, Zhao N. Smoke free or not: a pilot evaluation in selected Beijing hospitals. BMC Public Health. 2013;13:964.PubMedCentralPubMedCrossRef

46.

Xiao D, Wang C, Chen H, Hajek P. Making hospitals in China smoke free: a prospective study of implementing the new standard. Nicotine Tob Res. 2013;15(12):2076–80.PubMedCrossRef

47.

Royal College of Physicians and Royal College of Psychiatrists. Smoking and mental health. A joint report by the Royal College of Physicians and Royal College of Psychiatrists. London: Royal College of Physicians; 2013.

48.

Dyer C. Scottish judge rules smoking ban in psychiatric hospital breached patient's human rights. BMJ. 2013;347:f5343.PubMedCrossRef

49.

Lawn S. Cigarette smoking in psychiatric settings: occupational health, safety, welfare and legal concerns. Aust N Z J Psychiatry. 2005;39(10):886–91.PubMedCrossRef

50.

Etter JF, Ritter C, Christie DH, Kunz M, Rieder JP, Humair JP, et al. Implementation and impact of anti-smoking interventions in three prisons in the absence of appropriate legislation. Prev Med. 2012;55(5):475–81.PubMedCrossRef

51.

Ritter C, Huynh CK, Etter JF, Elger BS. Exposure to tobacco smoke before and after a partial smoking ban in prison: indoor air quality measures. Tob Control. 2012;21(5):488–91.PubMedCrossRef

52.

Gautam J, Glover M, Scott A, Welch D. Smokefree prisons in New Zealand: maximising the health gain. N Z Med J. 2011;124(1338):100–6.PubMed

53.

Thornley S, Dirks KN, Edwards R, Woodward A, Marshall R. Indoor air pollution levels were halved as a result of a national tobacco ban in a New Zealand prison. Nicotine Tob Res. 2013;15(2):343–7.PubMedCrossRef

54.

Kauffman RM, Ferketich AK, Murray DM, Bellair PE, Wewers ME. Tobacco use by male prisoners under an indoor smoking ban. Nicotine Tob Res. 2011;13(6):449–56.PubMedCentralPubMedCrossRef

55.

Bhaumik S. Ban on smoking in workplaces in India has led to more smoke free homes. BMJ. 2013;346:f2186.PubMedCrossRef

56.

Jarvis MJ, Sims M, Gilmore A, Mindell J. Impact of smoke-free legislation on children's exposure to secondhand smoke: cotinine data from the Health Survey for England. Tob Control. 2012;21(1):18–23.PubMedCrossRef

57.

Mons U, Nagelhout GE, Allwright S, Guignard R, van den Putte B, Willemsen MC, et al. Impact of national smoke-free legislation on home smoking bans: findings from the International Tobacco Control Policy Evaluation Project Europe surveys. Tob Control. 2013;22(e1):e2–9.PubMedCentralPubMedCrossRef

58.

Gilroy I, Donnelly N, Matthews W, Doherty K, Conlon G, Clarke AT, et al. Smoking in vehicles is lower than mobile telephone use while driving, but is socially patterned. Ir Med J. 2013;106(4):118–20.PubMed

59.

Glover M, Maifeleni T, Yeh CJ, Lee A, Gentles D. No need to ban smoking in cars with children present—it's almost snuffed out. N Z Med J. 2012;125(1358):84–8.PubMed

60.

Grimshaw GM, Stanton A. Tobacco cessation interventions for young people. Cochrane Database Syst Rev. 2006;4:CD003289.PubMed

61.

Veeranki SP, Mamudu HM, Anderson JL, Zheng S. Worldwide never-smoking youth susceptibility to smoking. J Adolesc Health. 2014;54(2):144–50.PubMedCrossRef

62.

Barr CD, Diez DM, Wang Y, Dominici F, Samet JM. Comprehensive smoking bans and acute myocardial infarction among Medicare enrollees in 387 US counties: 1999-2008. Am J Epidemiol. 2012;176(7):642–8.PubMedCentralPubMedCrossRef

63.

Dove MS, Dockery DW, Mittleman MA, Schwartz J, Sullivan EM, Keithly L, et al. The impact of Massachusetts' smoke-free workplace laws on acute myocardial infarction deaths. Am J Public Health. 2010;100(11):2206–12.PubMedCentralPubMedCrossRef

64.

Head P, Jackson BE, Bae S, Cherry D. Hospital discharge rates before and after implementation of a city-wide smoking ban in a Texas city, 2004-2008. Prev Chronic Dis. 2012;9:E179.PubMedCentralPubMedCrossRef

65.

Herman PM, Walsh ME. Hospital admissions for acute myocardial infarction, angina, stroke, and asthma after implementation of Arizona's comprehensive statewide smoking ban. Am J Public Health. 2011;101(3):491–6.PubMedCentralPubMedCrossRef

66.

Huesch MD, Ostbye T, Ong MK. Measuring the effect of policy interventions at the population level: some methodological concerns. Health Econ. 2012;21(10):1234–49.PubMedCrossRef

67.

Johnson EL, Beal JR. Impact of a comprehensive smoke-free law following a partial smoke-free law on incidence of heart attacks at a rural community hospital. Nicotine Tob Res. 2013;15(3):745–7.PubMedCrossRef

68.

Rodu B, Peiper N, Cole P. Acute myocardial infarction mortality before and after state-wide smoking bans. J Community Health. 2012;37(2):468–72.PubMedCrossRef

69.

Aguero F, Degano IR, Subirana I, Grau M, Zamora A, Sala J, et al. Impact of a partial smoke-free legislation on myocardial infarction incidence, mortality and case-fatality in a population-based registry: the REGICOR study. PLoS One. 2013;8(1):e53722.PubMedCentralPubMedCrossRef

70.

Barone-Adesi F, Gasparrini A, Vizzini L, Merletti F, Richiardi L. Effects of Italian smoking regulation on rates of hospital admission for acute coronary events: a country-wide study. PLoS One. 2011;6(3):e17419.PubMedCentralPubMedCrossRef

71.

Cronin EM, Kearney PM, Kearney PP, Sullivan P, Perry IJ. Impact of a national smoking ban on hospital admission for acute coronary syndromes: a longitudinal study. Clin Cardiol. 2012;35(4):205–9.PubMedCrossRef

72.

Stallings-Smith S, Zeka A, Goodman P, Kabir Z, Clancy L. Reductions in cardiovascular, cerebrovascular, and respiratory mortality following the national Irish smoking ban: interrupted time-series analysis. PLoS One. 2013;8(4):e62063.PubMedCentralPubMedCrossRef

73.

Kent BD, Sulaiman I, Nicholson TT, Lane SJ, Moloney ED. Acute pulmonary admissions following implementation of a national workplace smoking ban. Chest. 2012;142(3):673–9.PubMedCrossRef

74.

Liu A, Guzman Castillo M, Capewell S, Lucy J, O'Flaherty M. Reduction in myocardial infarction admissions in Liverpool after the smoking ban: potential socioeconomic implications for policymaking. BMJ Open. 2013;3(11):e003307.PubMedCentralPubMedCrossRef

75.

Christensen TM, Møller L, Jørgensen T, Pisinger C. The impact of the Danish smoking ban on hospital admissions for acute myocardial infarction. Eur J Prev Cardiol. 2014;2(1):65–73.CrossRef

76.

Bonetti PO, Trachsel LD, Kuhn MU, Schulzki T, Erne P, Radovanovic D, et al. Incidence of acute myocardial infarction after implementation of a public smoking ban in Graubunden Switzerland: two year follow-up. Swiss Med Wkly. 2011;141:w13206.PubMed

77.

Hauri DD, Lieb CM, Rajkumar S, Kooijman C, Sommer HL, Roosli M. Direct health costs of environmental tobacco smoke exposure and indirect health benefits due to smoking ban introduction. Eur J Public health. 2011;21(3):316–22.PubMedCrossRef

78.

de Korte-de BD, Kotz D, Viechtbauer W, van Haren E, Grommen D, de Munter M, et al. Effect of smoke-free legislation on the incidence of sudden circulatory arrest in the Netherlands. Heart. 2012;98:995–9.CrossRef

79.

Gaudreau K, Sanford CJ, Cheverie C, McClure C. The effect of a smoking ban on hospitalization rates for cardiovascular and respiratory conditions in Prince Edward Island Canada. PLoS One. 2013;8(3):e56102.PubMedCentralPubMedCrossRef

80.

Pell JP, Haw S, Cobbe S, Newby DE, Pell AC, Fischbacher C, et al. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med. 2008;359(5):482–91.PubMedCrossRef

81.

Mackay D, Haw S, Ayres JG, Fischbacher C, Pell JP. Smoke-free legislation and hospitalizations for childhood asthma. N Engl J Med. 2010;363(12):1139–45.PubMedCrossRef

82.

Schmucker J, Wienbergen H, Fach A, Seide S, Fiehn E, Gunther K, et al. Smoking ban in public areas is associated with reduced incidence of hospital admissions due to ST-elevation myocardial infarctions in non-smokers-results from the Bremen STEMI Registry. Circulation. 2013. doi:10.1177/2047487313483610.

83.

Adams J, Giles EL, Robalino S, McColl E, Sniehotta FF. A systematic review of the use of financial incentives and penalties to encourage uptake of healthy behaviors: protocol. Syst Rev. 2012;1:51.PubMedCentralPubMedCrossRef

84.

Been JV, Nurmatov U, van Schayck CP, Sheikh A. The impact of smoke-free legislation on fetal, infant and child health: a systematic review and meta-analysis protocol. BMJ Open. 2013;3:e002261.PubMedCentralPubMedCrossRef

85.

Cox B, Martens E, Nemery B, Vangronsveld J, Nawrot TS. Impact of a stepwise introduction of smoke-free legislation on the rate of preterm births: analysis of routinely collected birth data. BMJ. 2013;346:f441.PubMedCentralPubMedCrossRef

86.

Kabir Z, Daly S, Clarke V, Keogan S, Clancy L. Smoking ban and small-for-gestational age births in Ireland. PLoS One. 2013;8(3):e57441.PubMedCentralPubMedCrossRef

87.

Nguyen KH, Wright RJ, Sorensen G, Subramanian SV. Association between local indoor smoking ordinances in Massachusetts and cigarette smoking during pregnancy: a multilevel analysis. Tob Control. 2013;22(3):184–9.PubMedCentralPubMedCrossRef

88.

Page RL, Slejko JF, Libby AM. A citywide smoking ban reduced maternal smoking and risk for preterm births: a Colorado natural experiment. J Womens Health. 2012;21(6):621–7.CrossRef

Titel: An International Smoking Ban—How Many Lives Will Be Saved?
verfasst von: Cecily C Kelleher
Kate Frazer
Publikationsdatum: 01.06.2014
Verlag: Springer US
Erschienen in: Current Atherosclerosis Reports / Ausgabe 6/2014
Print ISSN: 1523-3804
Elektronische ISSN: 1534-6242
DOI: https://doi.org/10.1007/s11883-014-0418-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2014

2013 ACC/AHA Cholesterol Guideline for Reducing Cardiovascular Risk: What is so Controversial?

Renal Artery Stenosis—When To Screen, What To Stent?

Non-Invasive Imaging for Subclinical Coronary Atherosclerosis in Patients with Peripheral Artery Disease

Acute Revascularization in ST-Segment-Elevation Myocardial Infarction

Beyond Statins: New Lipid Lowering Strategies to Reduce Cardiovascular Risk